RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Hugues Ouellet to Mycobacterium tuberculosis

This is a "connection" page, showing publications Hugues Ouellet has written about Mycobacterium tuberculosis.
Connection Strength

3.300
  1. Ouellet H, Chow ED, Guan S, Cox JS, Burlingame AL, de Montellano PR. Genetic and mass spectrometric tools for elucidating the physiological function(s) of cytochrome P450 enzymes from Mycobacterium tuberculosis. Methods Mol Biol. 2013; 987:79-94.
    View in: PubMed
    Score: 0.402
  2. Ouellet H, Johnston JB, de Montellano PR. Cholesterol catabolism as a therapeutic target in Mycobacterium tuberculosis. Trends Microbiol. 2011 Nov; 19(11):530-9.
    View in: PubMed
    Score: 0.367
  3. Ouellet H, Kells PM, Ortiz de Montellano PR, Podust LM. Reverse type I inhibitor of Mycobacterium tuberculosis CYP125A1. Bioorg Med Chem Lett. 2011 Jan 01; 21(1):332-7.
    View in: PubMed
    Score: 0.346
  4. Ouellet H, Guan S, Johnston JB, Chow ED, Kells PM, Burlingame AL, Cox JS, Podust LM, de Montellano PR. Mycobacterium tuberculosis CYP125A1, a steroid C27 monooxygenase that detoxifies intracellularly generated cholest-4-en-3-one. Mol Microbiol. 2010 Aug; 77(3):730-42.
    View in: PubMed
    Score: 0.336
  5. Ouellet H, Johnston JB, Ortiz de Montellano PR. The Mycobacterium tuberculosis cytochrome P450 system. Arch Biochem Biophys. 2010 Jan 01; 493(1):82-95.
    View in: PubMed
    Score: 0.316
  6. Ouellet H, Lang J, Couture M, Ortiz de Montellano PR. Reaction of Mycobacterium tuberculosis cytochrome P450 enzymes with nitric oxide. Biochemistry. 2009 Feb 10; 48(5):863-72.
    View in: PubMed
    Score: 0.307
  7. Ouellet H, Podust LM, de Montellano PR. Mycobacterium tuberculosis CYP130: crystal structure, biophysical characterization, and interactions with antifungal azole drugs. J Biol Chem. 2008 Feb 22; 283(8):5069-80.
    View in: PubMed
    Score: 0.283
  8. Ouellet H, Juszczak L, Dantsker D, Samuni U, Ouellet YH, Savard PY, Wittenberg JB, Wittenberg BA, Friedman JM, Guertin M. Reactions of Mycobacterium tuberculosis truncated hemoglobin O with ligands reveal a novel ligand-inclusive hydrogen bond network. Biochemistry. 2003 May 20; 42(19):5764-74.
    View in: PubMed
    Score: 0.206
  9. Aguilera J, Karki CB, Li L, Vazquez Reyes S, Estevao I, Grajeda BI, Zhang Q, Arico CD, Ouellet H, Sun J. Na-Acetylation of the virulence factor EsxA is required for mycobacterial cytosolic translocation and virulence. J Biol Chem. 2020 04 24; 295(17):5785-5794.
    View in: PubMed
    Score: 0.165
  10. Zhang Q, Wang D, Jiang G, Liu W, Deng Q, Li X, Qian W, Ouellet H, Sun J. EsxA membrane-permeabilizing activity plays a key role in mycobacterial cytosolic translocation and virulence: effects of single-residue mutations at glutamine 5. Sci Rep. 2016 09 07; 6:32618.
    View in: PubMed
    Score: 0.130
  11. Johnston JB, Ouellet H, Ortiz de Montellano PR. Functional redundancy of steroid C26-monooxygenase activity in Mycobacterium tuberculosis revealed by biochemical and genetic analyses. J Biol Chem. 2010 Nov 19; 285(47):36352-60.
    View in: PubMed
    Score: 0.086
  12. Podust LM, Ouellet H, von Kries JP, de Montellano PR. Interaction of Mycobacterium tuberculosis CYP130 with heterocyclic arylamines. J Biol Chem. 2009 Sep 11; 284(37):25211-9.
    View in: PubMed
    Score: 0.079
  13. Podust LM, von Kries JP, Eddine AN, Kim Y, Yermalitskaya LV, Kuehne R, Ouellet H, Warrier T, Altek?ster M, Lee JS, Rademann J, Oschkinat H, Kaufmann SH, Waterman MR. Small-molecule scaffolds for CYP51 inhibitors identified by high-throughput screening and defined by X-ray crystallography. Antimicrob Agents Chemother. 2007 Nov; 51(11):3915-23.
    View in: PubMed
    Score: 0.069
  14. Dantsker D, Samuni U, Ouellet Y, Wittenberg BA, Wittenberg JB, Milani M, Bolognesi M, Guertin M, Friedman JM. Viscosity-dependent relaxation significantly modulates the kinetics of CO recombination in the truncated hemoglobin TrHbN from Mycobacterium tuberculosis. J Biol Chem. 2004 Sep 10; 279(37):38844-53.
    View in: PubMed
    Score: 0.056
  15. Mukai M, Ouellet Y, Ouellet H, Guertin M, Yeh SR. NO binding induced conformational changes in a truncated hemoglobin from Mycobacterium tuberculosis. Biochemistry. 2004 Mar 16; 43(10):2764-70.
    View in: PubMed
    Score: 0.055
  16. Mukai M, Savard PY, Ouellet H, Guertin M, Yeh SR. Unique ligand-protein interactions in a new truncated hemoglobin from Mycobacterium tuberculosis. Biochemistry. 2002 Mar 26; 41(12):3897-905.
    View in: PubMed
    Score: 0.048
  17. Sivaramakrishnan S, Ouellet H, Matsumura H, Guan S, Mo?nne-Loccoz P, Burlingame AL, Ortiz de Montellano PR. Proximal ligand electron donation and reactivity of the cytochrome P450 ferric-peroxo anion. J Am Chem Soc. 2012 Apr 18; 134(15):6673-84.
    View in: PubMed
    Score: 0.024
  18. Milani M, Ouellet Y, Ouellet H, Guertin M, Boffi A, Antonini G, Bocedi A, Mattu M, Bolognesi M, Ascenzi P. Cyanide binding to truncated hemoglobins: a crystallographic and kinetic study. Biochemistry. 2004 May 11; 43(18):5213-21.
    View in: PubMed
    Score: 0.014
  19. Milani M, Pesce A, Ouellet H, Guertin M, Bolognesi M. Truncated hemoglobins and nitric oxide action. IUBMB Life. 2003 Oct-Nov; 55(10-11):623-7.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support